Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 9
Submit an article Journal homepage
13,658
Views
160
CrossRef citations to date
0
Altmetric
Product Review

Tocilizumab (Actemra)

Martin SheppardSouthend University Hospital NHS Foundation Trust, Westcliff on Sea, UKCorrespondence[email protected] [email protected]
,
Faidra LaskouSouthend University Hospital NHS Foundation Trust, Westcliff on Sea, UK
,
Philip P. StapletonSouthend University Hospital NHS Foundation Trust, Westcliff on Sea, UK
,
Shahryar HadaviSouthend University Hospital NHS Foundation Trust, Westcliff on Sea, UK
&
Bhaskar DasguptaSouthend University Hospital NHS Foundation Trust, Westcliff on Sea, UKCorrespondence[email protected] [email protected]
Pages 1972-1988 | Received 01 Feb 2017, Accepted 31 Mar 2017, Published online: 22 Sep 2017

Citations (160)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Ting-Ting Yang, Ze-Yi Wang, Ze-Xin Fan, Bo-Yi Yuan, Lin Ma, Jian-Feng Lu, Pen-Ju Liu, Yang He & Guang-Zhi Liu. (2023) A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis. Journal of Inflammation Research 16, pages 5835-5843.
Read now
Alessandro Cuomo, Giovanni Barillà, Gianluca Serafini, Andrea Aguglia, Andrea Amerio, Matteo Cattolico, Pietro Carmellini, Alessandro Spiti & Andrea Fagiolini. (2023) Drug-drug interactions between COVID-19 therapeutics and psychotropic medications. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-12.
Read now
Lukas K van Vugt, Maaike R Schagen, Annelies de Weerd, Marlies EJ Reinders, Brenda CM de Winter & Dennis A Hesselink. (2022) Investigational drugs for the treatment of kidney transplant rejection. Expert Opinion on Investigational Drugs 31:10, pages 1087-1100.
Read now
Yuqin Xu, Wenjun Xu, Zhongxia Lu, Man Hei Cheung, Meiai Lin, Chun Liang, Jianshu Lou & Yitao Chen. (2022) Anti-Gastric Cancer Effect of Purified Omphalia lapidescens Protein via Regulating the JAK/STAT3 Signaling Pathway. Nutrition and Cancer 74:5, pages 1780-1791.
Read now
Ryan D Castle, Michelle A Williams, William C Bushell, J Adam Rindfleisch, Christine Tara Peterson, James Marzolf, Kimberly Brouwer & Paul J Mills. (2021) Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation. Journal of Inflammation Research 14, pages 4859-4876.
Read now
Reem Hanna, Snehal Dalvi, Tudor Sălăgean, Ioana Delia Pop, Ioana Roxana Bordea & Stefano Benedicenti. (2021) Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review. Journal of Inflammation Research 14, pages 13-56.
Read now
Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, Ettore Porreca, Antonella Cappelli, Antonio Abbate, Francesco Dentali & Aldo Bonaventura. (2021) The role of IL-6 and IL-6 blockade in COVID-19. Expert Review of Clinical Immunology 17:6, pages 601-618.
Read now
Noha Mousaad Elemam, Azzam A. Maghazachi & Suad Hannawi. (2021) COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies. Current Medical Research and Opinion 37:6, pages 929-938.
Read now
Maria Soledad Ormaechea, Muhammad Hassan, Neil Onghanseng, Jung Hyun Park, Sarakshi Mahajan, Khalid Yusuf Al-Kirwi, Gunay Uludag, Muhammad Sohail Halim, Ariel Schlaen, Yasir J Sepah, Diana V Do & Quan Dong Nguyen. (2019) Safety of systemic therapy for noninfectious uveitis. Expert Opinion on Drug Safety 18:12, pages 1219-1235.
Read now
Susan Patricia Mollan, John Horsburgh & Bhaskar Dasgupta. (2018) Profile of tocilizumab and its potential in the treatment of giant cell arteritis. Eye and Brain 10, pages 1-11.
Read now

Articles from other publishers (150)

Mostafa Khafaei, Reza Asghari, Fariba Zafari & Morteza Sadeghi. (2024) Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients. Cytokine 174, pages 156445.
Crossref
Mohamed Abdel-Salam Elgohary, Asmaa Ali, Sumaiah J.Alarfaj, Hesham Shahin, Ashraf Ibrahim Zaki, Eman Medhat Hasan, Mohamed Emam Mohamed, Ahmad Mahmoud Elkholy, Thanaa A. El-Masry, Jacklin Samir kamal, Mohammed Ali AbdelRahim, Ashgan Wageh Saber, Mohamed G Seadawy, Mohamed H.M. Elshishtawy & Maisra M. El-Bouseary. (2024) Even one dose of tocilizumab could hinder bad prognosis of cytokines storm in COVID-19 patients. Cytokine 173, pages 156433.
Crossref
Yue Xiong, Xiaohui Song, Xiangrui Sheng, Jian Wu, Xin Chang, Tian Ren, Jin Cao, Tao Cheng & Mingjun Wang. (2023) A review of Janus kinase/signal transducer and activator of transcription signaling and cytokines in the pain mechanism of rheumatoid arthritis. European Journal of Inflammation 21.
Crossref
T. Foiadelli, A. Santangelo, G. Costagliola, E. Costa, M. Scacciati, A. Riva, G. Volpedo, M. Smaldone, A. Bonuccelli, A. M. Clemente, A. Ferretti, S. Savasta, P. Striano & A. Orsini. (2023) Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay. Frontiers in Pediatrics 11.
Crossref
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, José Rubén García-Sánchez, José Correa-Basurto, Jazmín García-Machorro & Judith Espinosa-Raya. (2023) In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction. International Journal of Molecular Sciences 24:22, pages 16392.
Crossref
Viktoria Sharova, Vasilina Ignatiuk, Marina Izvolskaia & Liudmila Zakharova. (2023) Disruption of Intranasal GnRH Neuronal Migration Route into the Brain Induced by Proinflammatory Cytokine IL-6: Ex Vivo and In Vivo Rodent Models. International Journal of Molecular Sciences 24:21, pages 15983.
Crossref
Yenan Fang, Bingyan Shen, Qin Dai, Qiqi Xie, Wencan Wu & Min Wang. (2023) Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment. European Journal of Medical Research 28:1.
Crossref
Bernard Calvino. (2023) Inflammation aiguë, inflammation chronique - 4e partie. Pharmacologie inhibitrice des récepteurs de l’IL-6 (IL-6R, sIL-6r et sGP130). Douleurs : Évaluation - Diagnostic - Traitement 24:5-6, pages 266-270.
Crossref
Amy LiKamWa, Kaitlin Kobaitri & Balagangadhar R Totapally. (2023) A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab. Cureus.
Crossref
Prerna Sharma, Rahul V. Joshi, Robert Pritchard, Kevin Xu & Maya A. Eicher. (2023) Therapeutic Antibodies in Medicine. Molecules 28:18, pages 6438.
Crossref
X. Rebecca Sheng, Xia Gao, Courtney Schiffman, Jenny Jiang, Thirumalai R. Ramalingam, Celia J.F. Lin, Dinesh Khanna & Margaret Neighbors. (2023) Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis. Clinical Immunology 254, pages 109695.
Crossref
Barrett J. Burger, Sarenthia M. Epps, Victor M. Cardenas, Rajani Jagana, Nikhil K. Meena & William T. Atchley. (2023) Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. Life 13:8, pages 1752.
Crossref
Ying-Li Yang, Xiao-Feng Li, Biao Song, Sha Wu, Yuan-Yuan Wu, Cheng Huang & Jun Li. (2023) The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis. Rheumatology and Therapy 10:4, pages 793-808.
Crossref
Namthip Kaewbandit, Ashwini Malla, Wanuttha Boonyayothin, Kaewta Rattanapisit, Thareeya Phetphoung, Nuttapat Pisuttinusart, Richard Strasser, Rattana Saetung, Supannikar Tawinwung & Waranyoo Phoolcharoen. (2023) Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells. Scientific Reports 13:1.
Crossref
Panagiotis Athanassiou & Lambros Athanassiou. (2023) Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus. Life 13:7, pages 1496.
Crossref
Jakub Mizera, Justyna Pilch, Ugo Giordano, Magdalena Krajewska & Mirosław Banasik. (2023) Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review. Life 13:7, pages 1458.
Crossref
Tingyan He, Jiayun Ling & Jun Yang. (2023) Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis. Scientific Reports 13:1.
Crossref
Enrico Gugliandolo, Francesco Macrì, Roberta Fusco, Rosalba Siracusa, Marika Cordaro, Ramona D’amico, Alessio Filippo Peritore, Daniela Impellizzeri, Tiziana Genovese, Salvatore Cuzzocrea, Rosanna Di Paola & Rosalia Crupi. (2023) Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension. Pharmacological Research 192, pages 106750.
Crossref
Shafeeqa Gulam Khader, Wajith Hussain Zahir Hussain & Arumugam Moorthy. (2022) Rheumatology patients on immunosuppressive treatment and their perioperative management: Review of recommendations. Musculoskeletal Care 21:2, pages 571-575.
Crossref
Emir İZCİ, Fatih KESKİN, Bulent KAYA, Fatma Hümryra YERLİKAYA & Gökhan CÜCE. (2023) Effect of tocilizumab in subarachnoid hemorrhage-induced cerebral vasospasm of experimental rats. Journal of Health Sciences and Medicine 6:3, pages 699-704.
Crossref
Oscar Pizano-Martinez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Efrain Chavarria-Avila, Daniel Ortuño-Sahagún & Ana Laura Márquez-Aguirre. (2023) Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. Journal of Clinical Medicine 12:9, pages 3271.
Crossref
Hossam Nada, Aneesh Sivaraman, Qili Lu, Kyoungho Min, Sungdo Kim, Ja-Il Goo, Yongseok Choi & Kyeong Lee. (2023) Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure–Activity Relationships and Molecular Docking. Journal of Medicinal Chemistry.
Crossref
Antoniya Kamenova, Argyris Tzouvelekis & George A. Margaritopoulos. (2023) Recent advances in the treatment of systemic sclerosis associated interstitial lung disease. Frontiers in Medicine 10.
Crossref
Qian Ding, Wei Hu, Ran Wang, Qinyan Yang, Menglin Zhu, Meng Li, Jianghong Cai, Peter Rose, Jianchun Mao & Yi Zhun Zhu. (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Cristina Segú-Vergés, Laura Artigas, Mireia Coma & Richard W. Peck. (2023) Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome. PLOS ONE 18:2, pages e0280677.
Crossref
Vasilina Ignatiuk, Marina Izvolskaia, Viktoria Sharova & Liudmila Zakharova. (2023) Disruptions in Hypothalamic–Pituitary–Gonadal Axis Development and Their IgG Modulation after Prenatal Systemic Inflammation in Male Rats. International Journal of Molecular Sciences 24:3, pages 2726.
Crossref
Raghav Mishra, Kajal Chaudhary & Isha Mishra. (2023) Weapons and Strategies against COVID-19: A Perspective. Current Pharmaceutical Biotechnology 25:2, pages 144-158.
Crossref
Taghreed S Saeed Al-Rawi & Raid M Al-Ani. (2023) Liver dysfunction-related COVID-19: A narrative review. World Journal of Meta-Analysis 11:1, pages 5-17.
Crossref
Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge & Jun Ning. (2023) Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19. Future Virology 18:1, pages 63-74.
Crossref
KEMINE UZEL, IGOR LAKHNO, CAN TURKLER, MEHMET KUZUCU, GULCE NAZ YAZICI, RENAD MAMMADOV, BAHADIR SULEYMAN, AHMET KALE & HALIS SULEYMAN. (2023) Tocilizumab is effective in preventing ovarian injury induced by ischemia- reperfusion in rats. Anais da Academia Brasileira de Ciências 95:1.
Crossref
Sara Tenti, Olivier Bruyère, Sara Cheleschi, Jean-Yves Reginster, Nicola Veronese & Antonella Fioravanti. (2023) An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis. Therapeutic Advances in Musculoskeletal Disease 15, pages 1759720X2311586.
Crossref
Jianping Li, Yiqi Luo, Hao Li, Yunhong Yin & Yi Zhang. (2023) Research progress of viral sepsis: etiology, pathophysiology, diagnosis, and treatment. Emergency and Critical Care Medicine Publish Ahead of Print.
Crossref
Katie S. Turnbull & Martin E. Perry. 2023. Translational Autoimmunity. Translational Autoimmunity 181 205 .
Preeti Jain, Baldeep Singh, Sadhna Aggarwal & Manisha Singh. 2023. Multifaceted Role of IL-1 in Cancer and Inflammation. Multifaceted Role of IL-1 in Cancer and Inflammation 141 161 .
Jiaying Zhang, Jingxia Wang, Yiwen Gong, Yudan Gu, Qiangqiang Xiang & Ling-Ling Tang. (2022) Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia. BMC Infectious Diseases 22:1.
Crossref
Elif Tugce Sarcan, Stephen Paisey, Martin Ruthardt, Asuman Yekta Ozer, Christopher Marshall & Neil Hartman. (2022) 89Zr-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical. Journal of Radioanalytical and Nuclear Chemistry 331:12, pages 5507-5516.
Crossref
Hidetaka Suzuki, Shuichi Mitsunaga, Masafumi Ikeda, Takao Aoyama, Kazumi Yoshizawa, Masayuki Yamaguchi, Masami Suzuki, Minoru Narita, Toshikatsu Kawasaki & Atsushi Ochiai. (2022) Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer. Cancer Medicine 11:24, pages 5001-5012.
Crossref
Pengbo Zhang & Huang Zhu. (2022) Cytokines in Thyroid-Associated Ophthalmopathy. Journal of Immunology Research 2022, pages 1-12.
Crossref
Mohsen Rastkar, SeyedAhmad SeyedAlinaghi, Behzad Asanjarani, Goli Siri, Hamed Abdollahi, Ladan Ghadami, Mehrdad Hasibi, Rozita Khodashahi, AmirBehzad Bagheri & Ali Asadollahi‐Amin. (2022) The relationship between cumulative dose of immunosuppressive agents and COVID‐19‐associated mucormycosis: A multicenter cross‐sectional study. Health Science Reports 5:6.
Crossref
JiaXu Qin, XiangWei Zheng, YanChen He, Yang Hong, Shuang Liang & Xin Fang. (2022) The regulation of T helper cell polarization by the diterpenoid fraction of Rhododendron molle based on the JAK/STAT signaling pathway. Frontiers in Pharmacology 13.
Crossref
Ying-Shuang Li, Hua-Cheng Ren & Jian-Hua Cao. (2022) Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases. International Immunopharmacology 110, pages 109005.
Crossref
Catalina Ayón, Daniel Castán, Adrián Mora, Dunia Naranjo, Francini Obando & Juan José Mora. (2022) Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. Borneo Journal of Pharmacy 5:3, pages 229-246.
Crossref
Ekaterina A. Bryushkova, Valeria D. Skatova, Zinaida Y. Mutovina, Alena I. Zagrebneva, Daria S. Fomina, Tatyana S. Kruglova, Anna A. Akopyan, Irina D. Strazhesko, Sergey A. Lukyanov, Olga N. Tkacheva, Maryana A. Lysenko & Dmitry M. Chudakov. (2022) Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study. PLOS ONE 17:8, pages e0273340.
Crossref
Daniel Adesse, Luis Gladulich, Liandra Alvarez-Rosa, Michele Siqueira, Anne Caroline Marcos, Marialice Heider, Caroline Soares Motta, Silvia Torices, Michal Toborek & Joice Stipursky. (2022) Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19. Fluids and Barriers of the CNS 19:1.
Crossref
Satoshi Ebata, Asako Yoshizaki-Ogawa, Shinichi Sato & Ayumi Yoshizaki. (2022) New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics. Journal of Clinical Medicine 11:15, pages 4631.
Crossref
Hao Cheng, Xiao-ying Zhang, Hui-dan Yang, Zhen Yu, Cheng-lan Yan, Chong Gao & Hong-yan Wen. (2022) Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus. Frontiers in Immunology 13.
Crossref
Lei Zhang, Louise E. Pitcher, Matthew J. Yousefzadeh, Laura J. Niedernhofer, Paul D. Robbins & Yi Zhu. (2022) Cellular senescence: a key therapeutic target in aging and diseases. Journal of Clinical Investigation 132:15.
Crossref
Jin Huang, Chi Zhou, Jinniu Deng & Jianfeng Zhou. (2022) JAK inhibition as a new treatment strategy for patients with COVID-19. Biochemical Pharmacology 202, pages 115162.
Crossref
Merjona Saliaj, Matthew Li, Vincent Rizzo, Mahmoud Nassar, Nso Nso, Zarwa Idrees, Luis A. Medina, Anastasia Novikov, Salim Yaghi, Francisco J. Cuevas, Carolyn M. Salafia, Hamid Razaki, Charles Berman, Issac Sachmechi, Theo Trandafirescu, Debra Brennessel, George T. Martin & Jazila Mantis. (2022) Tocilizumab Treatment Reduces Mortality in Hospitalized Patients With COVID-19: A Retrospective Cohort Study at a New York City Hospital. Infectious Diseases in Clinical Practice 30:4.
Crossref
Lina M. León Machado, María O. Lopéz Oliva, Yanieli H. Hernandez Perdomo, Tamara Peréz, Elena González Garcia, Rafael Selgas Gutierrez & Carlos Jiménez Martín. (2022) Subcutaneous tocilizumab in chronic active humoral kidney graft rejection. Nefrología (English Edition) 42:4, pages 498-500.
Crossref
Lina M. León Machado, María O. Lopéz Oliva, Yanieli H. Hernandez Perdomo, Tamara Peréz, Elena González Garcia, Rafael Selgas Gutierrez & Carlos Jiménez Martín. (2022) Subcutaneous tocilizumab in chronic active humoral kidney graft rejection. Nefrología 42:4, pages 498-500.
Crossref
Benedikt Kowalski, Alan Valaperti, Pascal Bezel, Urs C. Steiner, Dieter Scholtze, Stephan Wieser, Maya Vonow-Eisenring, Andrea Widmer, Malcolm Kohler & Daniel Franzen. (2021) Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study. Journal of Cancer Research and Clinical Oncology 148:7, pages 1711-1720.
Crossref
Lauren M Gunderman, Taher Valika, Hallie Carol & Amer Khojah. (2022) Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor. BMJ Case Reports 15:6, pages e249191.
Crossref
Mostafa Abdelsalam, Ahmed M. Abd El Wahab, Mohammed Kamal Nassar, Emad Samaan, Ahmed Eldeep, Mohamed Abdalbary, Mona Tawfik, Marwa Saleh, Rasha Samir Shemies & Alaa Sabry. (2022) Kidneys in SARS‐CoV ‐2 era: A challenge of multiple faces . Therapeutic Apheresis and Dialysis 26:3, pages 552-565.
Crossref
Jacek Plichta, Piotr Kuna & Michał Panek. (2022) Monoclonal Antibodies as Potential COVID-19 Therapeutic Agents. COVID 2:5, pages 599-620.
Crossref
Bensu Karahalil & Aylin Elkama. (2022) COVID-19: Are Experimental Drugs a Cure or Cause?. Current Drug Safety 17:2, pages 83-89.
Crossref
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, Venkataramana Kandi, Ajit Behera, Sarika Verma, Kudrat‐E‐Zahan, Susanta K. Biswal, Taghreed H. Al‐Noor, Marei M. El‐ajaily, Ashish K. Sarangi & Kuldeep Dhama. (2022) SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic. Chemical Biology & Drug Design 99:5, pages 769-788.
Crossref
Vera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti & Eric Hollander. (2022) Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. Journal of Psychiatric Research 149, pages 367-373.
Crossref
Semra Demirli Atıcı, Mehmet Üstün, Emran Kuzey Avcı, Tayfun Kaya & Bülent Çalık. (2022) A Rare Cause of Right Lower Quadrant Abdominal Pain: Isolated Cecal Necrosis. Turkish Journal of Colorectal Disease 32:1, pages 31-35.
Crossref
Sara G. Manore, Daniel L. Doheny, Grace L. Wong & Hui-Wen Lo. (2022) IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment. Frontiers in Oncology 12.
Crossref
Giorgio Costagliola, Greta Depietri, Alexandre Michev, Antonella Riva, Thomas Foiadelli, Salvatore Savasta, Alice Bonuccelli, Diego Peroni, Rita Consolini, Gian Luigi Marseglia, Alessandro Orsini & Pasquale Striano. (2022) Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications. Frontiers in Neurology 13.
Crossref
Lucinda Villaescusa, Francisco Zaragozá, Irene Gayo-Abeleira & Cristina Zaragozá. (2022) A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab. Advances in Therapy 39:3, pages 1126-1148.
Crossref
Caterina Oriana Aragona, Antonio Giovanni Versace, Carmelo Ioppolo, Daniela La Rosa, Rita Lauro, Maria Concetta Tringali, Simona Tomeo, Guido Ferlazzo, William Neal Roberts, Alessandra Bitto, Natasha Irrera & Gianluca Bagnato. (2022) Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease. Biomedicines 10:2, pages 504.
Crossref
Agnieszka Sobkowiak-Sobierajska, Caroline Lindemans, Tomas Sykora, Jacek Wachowiak, Jean-Hugues Dalle, Halvard Bonig, Andrew Gennery & Anita Lawitschka. (2022) Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. Frontiers in Pediatrics 10.
Crossref
Fanny Ponthieux, Nicolas DaubyEvelyne MaillartJean-François FilsJulie SmetMarc ClausTatiana Besse-HammerDavid De BelsFrancis CorazzaCarole Nagant. (2022) Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6. Viral Immunology.
Crossref
Maurizio Gabrielli, Laura Franza, Alessandra Esperide, Irene Gasparrini, Antonio Gasbarrini & Francesco Franceschi. (2022) Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines 10:2, pages 192.
Crossref
Hua Liao, Juan Du, Taotao Li & Lili Pan. (2022) Tocilizumab for faster and safer remission of Takayasu’s arteritis. Therapeutic Advances in Chronic Disease 13, pages 204062232211317.
Crossref
Win Min Oo & David J. Hunter. (2022) Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210902.
Crossref
Noha Samir Taibe, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj & Mahmoud M. Elhefnawi. (2022) Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Therapeutic Advances in Respiratory Disease 16, pages 175346662211327.
Crossref
Ling Liu, Wenjun Zhou, Yujie Fan, Liming Zhang, Shichun Liu, Shengfang Song & Hua Li. (2022) Effect of Interleukin 6 on Scleral Fibroblast Proliferation, Differentiation, and Apoptosis Involved in Myopic Scleral Remodeling. Ophthalmic Research 65:5, pages 529-539.
Crossref
Hossam Kamli, Evan P. Owens, David A. Vesey, Rajagopalan Prasanna, Li Li, Glenda C. Gobe & Christudas Morais. (2022) Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects. Biochemical and Biophysical Research Communications 586, pages 42-48.
Crossref
Tiago Borges, Arsénio Barbosa & Sérgio Silva. 2022. Translational Autoimmunity. Translational Autoimmunity 83 114 .
Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, Massimo Lupi, Giuliana Zanelli, Tiziana Salviato, Matteo Costantini, Tommaso Trenti & Antonio Maiorana. (2021) HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19. Annals of Hematology 101:1, pages 229-231.
Crossref
Peter Noll, Michael Goldenberg, Suchita Sampath, Jaimie Rodger & Shannon C. Trotter. 2022. Clinical Cases in Alopecia. Clinical Cases in Alopecia 153 159 .
Elise Liu, Léa Karpf & Delphine Bohl. (2021) Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons. Frontiers in Molecular Neuroscience 14.
Crossref
Nicolas Lambert, Isabelle Hansen, Majdouline El Moussaoui, Jean‐Baptiste Giot, Christelle Vercheval, Émilie Lommers, Joan Somja, Michel Moutschen & Pierre Maquet. (2021) Lung and liver sarcoidosis‐like reaction induced by tocilizumab. British Journal of Clinical Pharmacology 87:12, pages 4848-4852.
Crossref
Joana Rodrigues, Daniela Santos-Faria, Joana Silva, Soraia Azevedo, Francisca Guimarães, Diogo Esperança Almeida, Filipa Teixeira, Daniela Peixoto, Sérgio Alcino, Carmo Afonso & José Tavares-Costa. (2021) Treating Adult-Onset Still Disease With Tocilizumab. JCR: Journal of Clinical Rheumatology 27:8S, pages S414-S415.
Crossref
Swathi Beladakere Ramaswamy, Shivangi Singh, Sara Hooshmand, Cho Junsang, Megan Sweeney & Raghav Govindarajan. (2021) Current and Upcoming Treatment Modalities in Myasthenia Gravis. Journal of Clinical Neuromuscular Disease 23:2, pages 75-99.
Crossref
Kamna Srivastava & Mohan Kumar Singh. (2021) Drug repurposing in COVID-19: A review with past, present and future. Metabolism Open 12, pages 100121.
Crossref
Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin & Zhe-Sheng Chen. (2021) Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment. Frontiers in Pharmacology 12.
Crossref
Anna-Lena Mueller, Zahra Payandeh, Niloufar Mohammadkhani, Shaden M. H. Mubarak, Alireza Zakeri, Armina Alagheband Bahrami, Aranka Brockmueller & Mehdi Shakibaei. (2021) Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 10:11, pages 3017.
Crossref
Takwa E. Meawed, Sherweet M. Ahmed, Sherif M.S. Mowafy, Ghada M. Samir & Reham H. Anis. (2021) Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. Journal of Infection and Public Health 14:10, pages 1375-1380.
Crossref
Zeynab Mohamadi Yarijani & Houshang Najafi. (2021) Kidney injury in COVID-19 patients, drug development and their renal complications: Review study. Biomedicine & Pharmacotherapy 142, pages 111966.
Crossref
Arturo J Martí-Carvajal, Juan Bautista De Sanctis, Mark Dayer, Cristina Elena Martí-Amarista, Eduardo Alegría, Diana Monge Martín, Mohamed Abd El Aziz, Andrea Correa-Pérez, Susana Nicola & Juan Marcos Parise Vasco. (2021) Interleukin-receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews 2021:9.
Crossref
Bogna Grygiel-Górniak, Osama Shaikh, Nikita Niranjan Kumar, Shao Heng Hsu & Włodzimierz Samborski. (2021) Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients. Rheumatology 59:4, pages 252-259.
Crossref
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Vikas & Madaswamy S Muthu. (2021) Harnessing immunological targets for COVID-19 immunotherapy. Future Virology 16:9, pages 619-640.
Crossref
Baris Mustafa Poyraz, Evren Doruk Engin, Ayse Basak Engin & Atilla Engin. (2021) The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity. Environmental Toxicology and Pharmacology 86, pages 103657.
Crossref
Amal Saki, Elham Rajaei & Fakher Rahim. (2021) Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies. Rheumatology 59:3, pages 169-179.
Crossref
Donovan A. McGrowder, Fabian Miller, Melisa Anderson Cross, Lennox Anderson-Jackson, Sophia Bryan & Lowell Dilworth. (2021) Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 9:3, pages 50.
Crossref
Florencia S. Pierini, Eliana Botta, Enrique R. Soriano, Maximiliano Martin, Laura Boero, Tomás Meroño, María Soledad Saez, Ezequiel Lozano Chiappe, Osvaldo Cerda, Gustavo Citera, Ignacio Gandino, Javier Rosa, Patricia Sorroche, Anatol Kontush & Fernando Brites. (2021) Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study. Rheumatology and Therapy 8:2, pages 803-815.
Crossref
Duygu Ağagündüz, Menşure Nur Çelik, Merve Esra Çıtar Dazıroğlu & Raffaele Capasso. (2021) Emergent Drug and Nutrition Interactions in COVID-19: A Comprehensive Narrative Review. Nutrients 13:5, pages 1550.
Crossref
Gaurav Doshi & Ami Thakkar. (2021) Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis. Current Drug Targets 22:7, pages 803-815.
Crossref
Atalay DOĞRU. (2021) Covid-19 Hastalığında Anti-sitokin Tedaviler: IL-6 Reseptör İnhibitörü (Tosilizumab) ve IL-1 Reseptör Antagonisti (Anakinra)Anti-cytokine treatments in Covid-19 disease: IL-6 receptor inhibitor (Tocilizumab) and IL-1 receptor antagonist (Anakinra). SDÜ Tıp Fakültesi Dergisi 28:COVİD-19 ÖZEL SAYI, pages 163-166.
Crossref
G. Pomponio, A. Ferrarini, M. Bonifazi, M. Moretti, A. Salvi, A. Giacometti, M. Tavio, G. Titolo, L. Morbidoni, G. Frausini, M. Onesta, D. Amico, M. L. B. Rocchi, S. Menzo, L. Zuccatosta, F. Mei, V. Menditto, S. Svegliati, A. Donati, M. M. D'Errico, M. Pavani & A. Gabrielli. (2021) Tocilizumab in COVID‐19 interstitial pneumonia. Journal of Internal Medicine 289:5, pages 738-746.
Crossref
Doaa A. Ghareeb, Samar R. Saleh, Mohammed S. Nofal, Mohamed M. Y. Kaddah, Salma. F. Hassan, Inas K. Seif, Sally A. El-Zahaby, Shaimaa M. Khedr, Marwa Y. Kenawy, Aliaa A. Masoud, Salma A. Soudi, Ahmed A. Sobhy, Jaillan G. Sery, Miral G. Abd El-Wahab, Alshimaa A. Abd Elmoneam, Abdulaziz Mohsen Al-mahallawi & Maha A. El-Demellawy. (2021) Potential therapeutic and pharmacological strategies for SARS-CoV2. Journal of Pharmaceutical Investigation 51:3, pages 281-296.
Crossref
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, Amjad Khan, Anupam A Sule, Raghavendra Tirupathi, Abbas Al Mutair, Saad Alhumaid, Awad Al-Omari, Manish Dhawan, Ruchi Tiwari, Khan Sharun, Ranjan K. Mohapatra, Saikat Mitra, Muhammad Bilal, Salem A. Alyami, Talha Bin Emran, Mohammad Ali Moni & Kuldeep Dhama. (2021) Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines 9:5, pages 436.
Crossref
Marta Bodro, Frederic Cofan, Jose Ríos, Sabina Herrera, Laura Linares, María Angeles Marcos, Alex Soriano, Asunción Moreno & Fritz Diekmann. (2021) Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19. Journal of Clinical Medicine 10:8, pages 1551.
Crossref
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araujo, Luciane Vieira de Oliveira Rosario & Valéria Pereira Ferrer. (2021) Endothelial cells and SARS-CoV-2: An intimate relationship. Vascular Pharmacology 137, pages 106829.
Crossref
Taciana de Albuquerque Pedrosa Fernandes, Francisco Hugo Rodrigues Gomes & Fabíola Donato de Almeida Kuchiki. (2021) Manejo dos biológicos em crianças e adolescentes com doenças reumáticas autoimunes. Revista Paulista de Reumatologia:2021 jan-mar;20(1), pages 27-36.
Crossref
Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella & Girolamo Pelaia. (2021) Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. International Journal of Molecular Sciences 22:6, pages 3059.
Crossref
Francisco Vílchez-Oya, Ana Pros, Irene Carrión-Barberà, Juan Antonio Meraz-Ostíz, Tarek Carlos Salman-Monte & Carolina Pérez-García. (2021) Le tocilizumab peut induire une hypogammaglobulinémie secondaire. Série rétrospective de 42 patients. Revue du Rhumatisme 88:2, pages 152-155.
Crossref
Z. Khan, Y. Karataş, A.F. Ceylan & H. Rahman. (2021) COVID-19 and therapeutic drugs repurposing in hand: The need for collaborative efforts. Le Pharmacien Hospitalier et Clinicien 56:1, pages 3-11.
Crossref
Natasha N. Pettit, Cynthia T. Nguyen, Gökhan M. Mutlu, David Wu, Lucas Kimmig, David Pitrak & Kenneth Pursell. (2020) Late onset infectious complications and safety of tocilizumab in the management of COVID‐19. Journal of Medical Virology 93:3, pages 1459-1464.
Crossref
Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, Pottathil Shinu, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Satyendra Deka & Vinayak Singh. (2021) Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Frontiers in Molecular Biosciences 8.
Crossref
Jorge Barriuso, Raghavendar T. Nagaraju, Shreya Belgamwar, Bipasha Chakrabarty, George J. Burghel, Helene Schlecht, Lucy Foster, Elaine Kilgour, Andrew J. Wallace, Michael Braun, Caroline Dive, D. Gareth Evans, Robert G. Bristow, Mark P. Saunders, Sarah T. O'Dwyer & Omer Aziz. (2021) Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of “Stemness” Programs and Local Inflammation. Clinical Cancer Research 27:4, pages 1119-1130.
Crossref
Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Taher Entezari‐Maleki, Touraj Asvadi‐Kermani & Masoud Nouri‐Vaskeh. (2021) Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview. Pharmacology Research & Perspectives 9:1.
Crossref
A. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav & M. Cecconi. (2021) Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review. Pulmonology 27:1, pages 52-66.
Crossref
Beate Bittner & Johannes Schmidt. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems 159 179 .
Erkut ETÇİOĞLU, Deniz ÇEKİÇ, Kubilay İŞSEVER, Ahmed Cihad GENÇ, Abdülkadir AYDIN & Selcuk YAYLACI. (2020) COVID-19 Hastasında Tosilizumab Kullanımı Sonrası Gelişen Karaciğer ToksisitesiLiver Toxicity After the Use of Tocilizumab in COVID-19 Patient. Journal of Biotechnology and Strategic Health Research 4:3, pages 333-337.
Crossref
Liudmila Zakharova, Viktoria Sharova & Marina Izvolskaia. (2020) Mechanisms of Reciprocal Regulation of Gonadotropin-Releasing Hormone (GnRH)-Producing and Immune Systems: The Role of GnRH, Cytokines and Their Receptors in Early Ontogenesis in Normal and Pathological Conditions. International Journal of Molecular Sciences 22:1, pages 114.
Crossref
Jeremy C. McMurray, Joseph W. May, Madeleine W. Cunningham & Olcay Y. Jones. (2020) Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment. Frontiers in Pediatrics 8.
Crossref
Gianluca Villa, Stefano Romagnoli, Silvia De Rosa, Massimiliano Greco, Marco Resta, Diego Pomarè Montin, Federico Prato, Francesco Patera, Fiorenza Ferrari, Giuseppe Rotondo & Claudio Ronco. (2020) Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study. Critical Care 24:1.
Crossref
Hiren N. Patel, Asma Syed, Jeffrey S. Lobel, Robert Galler, Joseph Georges, Margaret Carmody & Micheal Puumala. (2020) Cerebellar infarction requiring surgical decompression in patient with COVID 19 pathological analysis and brief review. Interdisciplinary Neurosurgery 22, pages 100850.
Crossref
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar & Raj Kumar Singh. (2020) Drug repurposing approach to fight COVID-19. Pharmacological Reports 72:6, pages 1479-1508.
Crossref
Luca Bernardo, Stefania Del Sesto, Laura Giordano, Anna Rita Benincaso, Piero Biondi, Vinicio Goj, Francesca Ferrara, Antonella Talenti, Antonella Grisolia & Paolo Antonio Ascierto. (2020) Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature. Drugs & Therapy Perspectives 36:12, pages 568-572.
Crossref
Joseph Meletiadis, Sotirios Tsiodras & Panagiotis Tsirigotis. (2020) Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19. Infectious Diseases and Therapy 9:4, pages 707-713.
Crossref
Karissa C. Arthur, Elizabeth Fracica & Michelle C. Johansen. (2020) Stroke Treatment in the Setting of Systemic Disease. Current Treatment Options in Neurology 22:12.
Crossref
Reena Sherin Parveen, Sherya HegdeVeena Nayak. (2020) Investigational Drugs for the COVID 19 Pandemic – A Concise Review . Pharmaceutical Sciences 26:Covid-19, pages S36-S48.
Crossref
Karolina Akinosoglou & Charalambos Gogos. (2020) Severe COVID ‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern . Respirology 25:11, pages 1209-1209.
Crossref
Farzaneh Dastan, Ali Saffaei, Sara Haseli, Majid Marjani, Afshin Moniri, Zahra Abtahian, Atefeh Abedini, Arda Kiani, Sharareh Seifi, Hamidreza Jammati, Seyed Mohammad Reza Hashemian, Mihan Pourabdollah Toutkaboni, Alireza Eslaminejad, Jalal Heshmatnia, Mohsen Sadeghi, Seyed Alireza Nadji, Alireza Dastan, Parvaneh Baghaei, Mohammad Varahram, Sahar Yousefian, Jamshid Salamzadeh & Payam Tabarsi. (2020) Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. International Immunopharmacology 88, pages 106869.
Crossref
Francisco Vílchez-Oya, Ana Pros, Irene Carrión-Barberà, Juan Antonio Meraz-Ostíz, Tarek Carlos Salman-Monte & Carolina Pérez-García. (2020) Tocilizumab may induce secondary hypogammaglobulinaemia. A retrospective case series of 42 patients. Joint Bone Spine 87:5, pages 503-505.
Crossref
Melanie Bilbul, Patricia Paparone, Anna M. Kim, Shruti Mutalik & Carrie L. Ernst. (2020) Psychopharmacology of COVID-19. Psychosomatics 61:5, pages 411-427.
Crossref
Hamidreza Samaee, Monireh Mohsenzadegan, Shahram Ala, Shahnam Sedigh Maroufi & Parisa Moradimajd. (2020) Tocilizumab for treatment patients with COVID-19: recommended medication for novel disease. International Immunopharmacology, pages 107018.
Crossref
Giulio Nittari, Graziano Pallotta, Francesco Amenta & Seyed Khosrow Tayebati. (2020) Current pharmacological treatments for SARS-COV-2: A narrative review. European Journal of Pharmacology 882, pages 173328.
Crossref
Mamiko Anada, Miyoka Tohyama, Yoshitaka Oda, Yuuta Kamoshima, Itaru Amino, Fumihito Nakano, Yusei Miyazaki, Sachiko Akimoto, Naoya Minami, Seiji Kikuchi, Satoshi Terae & Masaaki Niino. (2020) Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis. Internal Medicine 59:16, pages 2053-2059.
Crossref
Rinat K. Raupov & Mikhail M. Kostik. (2020) Juvenile Localized Scleroderma. Questions of Treatment. Current Pediatrics 19:3, pages 228-234.
Crossref
Ellen WeisbergMartin SattlerPriscilla L. YangAlexander ParentNathanael GrayJames D. Griffin. (2020) Current therapies under investigation for COVID-19: potential COVID-19 treatments. Canadian Journal of Physiology and Pharmacology 98:8, pages 483-489.
Crossref
Cong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Jixin Zhong & Lingli Dong. (2020) Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Annals of the Rheumatic Diseases 79:8, pages 1007-1013.
Crossref
Damir Muhović, Jelena Bojović, Ana Bulatović, Batrić Vukčević, Marina Ratković, Ranko Lazović & Brigita Smolović. (2020) First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19. Liver International 40:8, pages 1901-1905.
Crossref
Linzi Fan, Shuang Jiang, Xinrong Yang, Zhibin Wang & Chunjuan Yang. (2020) COVID-19 Drug Treatment in China. Current Pharmacology Reports 6:4, pages 146-154.
Crossref
Faryal Farooqi, Naveen Dhawan, Richard Morgan, John Dinh, Kester Nedd & George Yatzkan. (2020) Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review. Tropical Medicine and Infectious Disease 5:3, pages 112.
Crossref
Mansoor Khalid, Tarek Dernaika, Lirin Jacob, Pavan Annamaraju & Achuta K. Guddati. (2020) Weather the Cytokine Storm: A Report of Successful Management of a Colon Cancer Survivor and a Critically Ill Patient with COVID-19. Case Reports in Oncology 13:2, pages 754-759.
Crossref
Ryan Kolb & Weizhou Zhang. (2020) Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue. Cancers 12:6, pages 1686.
Crossref
Maria Laura Belladonna & Ciriana Orabona. (2020) Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19. Frontiers in Pharmacology 11.
Crossref
Piero Sestili & Vilberto Stocchi. (2020) Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19. Frontiers in Pharmacology 11.
Crossref
Mikel Rojo, Oscar Cano-Valderrama, Sara Picazo, Carlos Saez, Lorena Gómez, Cristina Sánchez, Gonzalo Sanz-Ortega & Antonio J. Torres. (2020) Gastrointestinal Perforation After Treatment With Tocilizumab. The American Surgeon 86:6, pages 565-566.
Crossref
Laure ElensLoralie J. LangmanDennis A. HesselinkStein BerganDirk Jan A.R. MoesMariadelfina MolinaroRaman VenkataramananFlorian Lemaitre. (2020) Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions. Therapeutic Drug Monitoring 42:3, pages 360-368.
Crossref
H. S. Lyons, V. Quick, A. J. Sinclair, S. Nagaraju & S. P. Mollan. (2019) A new era for giant cell arteritis. Eye 34:6, pages 1013-1026.
Crossref
V. S. Smirnov & Areg A. Totolian. (2020) Some opportunities for immunotherapy in coronavirus infection. Russian Journal of Infection and Immunity 10:3, pages 446-458.
Crossref
Steven Douedi & Jeffrey Miskoff. (2020) Novel coronavirus 2019 (COVID-19). Medicine 99:19, pages e20207.
Crossref
Zhiqiang Ku, Xiaohua Ye, Georgina To’a Salazar, Ningyan Zhang & Zhiqiang An. (2020) Antibody therapies for the treatment of COVID-19. Antibody Therapeutics 3:2, pages 101-108.
Crossref
Amanda M. Rivera, Scott May, Matthew Lei, Stephanie Qualls, Katelyn Bushey, Daniel B. Rubin & Megan E. Barra. (2020) CAR T-Cell-Associated Neurotoxicity. Critical Care Nursing Quarterly 43:2, pages 191-204.
Crossref
Anna-Sophia Kattner, Ernst Holler, Barbara Holler, Sebastian Klobuch, Daniela Weber, Danilo Martinovic, Matthias Edinger, Wolfgang Herr & Daniel Wolff. (2020) IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Annals of Hematology 99:4, pages 847-853.
Crossref
Kathryn A. Wierenga, Jack R. Harkema & James J. Pestka. (2019) Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions. Toxicologic Pathology 47:8, pages 1004-1011.
Crossref
Emma Miler, Philip P. Stapleton, Sarah Mapplebeck, Craig Mackerness, Dawn Gayford, Tin Aung, Lisa Wilson, Paul Schofield & Bhaskar Dasgupta. (2019) Circulating interleukin‐6 as a biomarker in a randomized controlled trial of modified‐release prednisone vs immediate‐release prednisolone, in newly diagnosed patients with giant cell arteritis. International Journal of Rheumatic Diseases 22:10, pages 1900-1904.
Crossref
Aly M. Abdelrahman, Yousuf Al Suleimani, Asem Shalaby, Mohammed Ashique, Priyadarsini Manoj & Badreldin H. Ali. (2019) Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 392:8, pages 1005-1013.
Crossref
Alvin Lee Day & Jasvinder A. Singh. (2019) Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?. Drugs & Aging 36:6, pages 493-510.
Crossref
Nadiya B. Kuryltsiv & Kateryna M. Halei. (2019) THE ROLE OF INTERLEUKINS AND THEIR INHIBITORS IN THE DEVELOPMENT OF AUTOIMMUNE UVEITIS. Wiadomości Lekarskie 72:4, pages 716-722.
Crossref
Anthony Behin & Rozen Le Panse. (2018) New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis. Journal of Neuromuscular Diseases 5:3, pages 265-277.
Crossref
Michael R. Pranzatelli. (2018) Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. Frontiers in Immunology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.